Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for perioperative management in elderly patients with hypertension
ChiCTR-IPR-16009442Phase 4Recruiting
- Sponsor
- Xiangyang No.1 People's Hospital
- Start
- Oct 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and sufentanil in hypertension (HTN) (4 arms), sponsored by Xiangyang No.1 People's Hospital. Primary endpoint: blood pressure. Started Oct 2016; status: recruiting.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-IPR-16009442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009442.